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Introduction: There are at least 40 types of Legionella bacteria, half of which are capable 
of producing disease in humans. The Legionella pneumophila bacterium, the root cause of 
  Legionnaires’ disease, causes 90% of legionellosis cases.
Case presentation: We describe the case of a 60-year-old woman with a history of diabetes 
mellitus and arterial hypertension who was admitted to our hospital with fever and symptoms 
of respiratory infection, diarrhea, and acute renal failure. We used real-time polymerase chain 
reaction (PCR) to detect L. pneumophila DNA in peripheral blood and serum samples and 
urine antigen from a patient with pneumonia. Legionella DNA was detected in all two sample 
species when first collected.
Conclusion: Since Legionella is a cause of 2% to 15% of all community-acquired pneumonias 
that require hospitalization, legionellosis should be taken into account in an atypical pulmonary 
infection and not be forgotten. Moreover, real-time PCR should be considered a useful diagnostic 
method.
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Introduction
Legionella species are Gram-negative bacteria that are ubiquitous in both natural 
aquatic and moist soil and muddy environments and in artificial aquatic habitats.1,2 
Human infection with Legionella spp. has two distinct forms: Legionnaires’ 
  disease, a more severe form of infection which includes pneumonia, and Pontiac 
Fever, a milder febrile flu-like illness without pneumonia.3 Legionella stands as the 
cause of   community-acquired pneumonia (CAP) in 2%–15% of all CAPs that require 
  hospitalization. The clinical and radiological features of Legionella pneumonia 
are nonspecific, and the diagnosis depends on laboratory tests.4 This paper reports 
a case of pneumonia caused by Legionella pneumophila that was admitted to the 
general hospital of Komotini in Greece.
Case report
A 60-year-old female with a history of diabetes mellitus, chronic obstructive   pulmonary 
disease, and arterial hypertension with a 4-day history of watery diarrhea and   temperature 
was admitted to our hospital. The findings from physical   examinations on admission were 
as follows: temperature 38.6°C, blood pressure 130/95 mm Hg, heart rate 117 beats/min, 
and respiratory rate 28 breaths/min. Chest auscultation revealed crackles on the left 
lower lung field. Laboratory findings on admission were as follows: white blood cell 
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rate (ESR) was 110/h,   procacitonin (PCT) 2 ng/mL, C-reactive 
  protein (CRP) 14 mg/dL (Table 1). We considered the elevated 
  creatinine levels as acute, because at her previous laboratory 
tests her creatinine values never surpassed 1.3 mg/dL. Arterial 
blood gas showed hypoxemia, as partial pressure of oxygen on 
air was 56 mm Hg.5 The chest X-ray showed infiltration of the 
left lung (  Figure 1). With a clinical   diagnosis of pneumonia, 
urine samples for L. pneumophila and Streptococcus 
pneumoniae antigen, gram stain sputum, and blood specimens 
upon admission were collected from the patient for culture 
testing.6 The results were reported negative. The pneumonia 
severity index (PSI) was   evaluated as class 3 with a mortality 
rate of 0.9%.7 The patient was treated empirically with 1 g 
amoxycillin/  clavulanic acid three times daily and 500 mg 
clarithromycin two times daily for 2 days. Empiric antibiotic 
treatment was added upon admission based on elevated 
values of CRP, WBC, ESR, and chest X-ray findings, since 
early antibiotic treatment prevents progression of the disease 
and these markers are known to be elevated in infectious 
diseases.8,9 The clinical status of the patient was deteriorating, 
and there was a marked progression of the infiltrates on the 
chest X-ray; the left infiltrate progressed to bilateral shadows. 
The   laboratory values were as follows on the 2nd hospital 
day: WBC count 17,780/µL, CRP 18 mg/dL, PCT 2 ng/mL, 
and ESR 120/h. The patient’s hypoxemia increased: partial 
pressure of   oxygen in arterial blood (PaO2) 47 mmHg, partial 
pressure of carbon dioxide in arterial blood (PaCO2) 25.4 mm 
Hg, and pH 7.5 (Table 1). The patient’s respiratory rate 
increased 30/h. One day after her admission to hospital (day 2) 
(  Figure 2), two blood samples, one serum sample and a second 
urine sample were taken and tested for L. pneumophila with a 
real-time polymerase chain reaction (PCR) kit (Aqua Screen 
L. pneumophila-detection kit for real-time PCR; Minerva 
Biolabs, Minerva, OH) and with culture method. The test 
revealed positive for L. pneumophila. A portion of 200 µL of 
blood and an equal volume of serum were plated on buffered 
charcoal yeast extract (BCYE) (Oxoid, Reading, UK) with 
L-cysteine, on BCYE without L-cysteine, and on GVPC (gas 
vesicle protein C). No growth of Legionella spp. was noticed 
after several days of incubation. The   Legionella urinary antigen 
detection test was positive.
The antibiotics were immediately changed to   levofloxacin 
after the positive real-time PCR and Legionella urinary 
  antigen detection test. The patient responded after therapy 
with levofloxacin, on day four (Figure 3). Her general 
condition, as well as radiographic and laboratory findings, 
gradually improved and the patient was discharged on the 
21st day of hospitalization (Figure 4).
To identify the source of the infection, the patient’s 
relatives were interviewed. Exposure histories revealed that 
the patient had travelled abroad and visited an   operating spa 
pool 2 weeks before the day of onset. After she returned, 
she remained in her village until her admission to hospital. 
As there were no cooling towers or any aerosol-generating 
systems in an area of 2 km from the house, and there was 
no access to the spa pool abroad, environmental samples 
were taken only from the home water supplies, and   standard 
methods were processed. Water samples revealed an absence 
of Legionella spp. from the domestic water supplies.
Table 1 Laboratory findings
Finding On admission 2nd day
WBC 14,280/µL 17,780/µL
  Neutrophils 89.4% 88.3%
  Lymphocytes 7% 7%
  Basophils 0.1% 0.1%
  eosinophils 0.1% 0.1%
  Monocytes 3.4% 3.5%
AsT 38 IU/L 42 IU/L
ALT 33 IU/L 35 IU/L
LDH 434 IU/L 500 IU/L
Ur 107 mg/dL 1110 mg/dL
Cr 3.4 mg/dL 3.5 mg/dL
Na 123 mmol/L 123 mmol/L
K 4.4 mmol/L 4 mmol/L
CrP 14 mg/dL 18 mg/dL
esr 110/h 120/h
PCT 2 ng/mL 2 ng/mL
PaO2 56 mmHg 47 mmHg
PaCO2 30 mmHg 25 mmHg
pH 7.497 7.5
Abbreviations: ALT, alanine transaminase; AsT, aspartate transaminase; Cr, crea-
tinine; CrP, C-reactive protein; esr, erythrocyte sedimentation rate; LDH, lactate 
dehydrogenase; PaCO2, partial pressure of carbon dioxide in arterial blood; PaO2, 
partial pressure of oxygen in arterial blood; PCT, procacitonin; Ur, urea; WBC, white 
blood cell.
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Discussion
The incidence of Legionnaires’ disease has increased in 
the last decade since the introduction of urinary antigen 
immunoassays.10,11 This test accounts for most of the 
  diagnostics due to its high sensitivity and ease of use.12 
L. pneumophila has become one of the leading causes of 
CAP in adults, accounting for 6%–14% of cases requiring 
hospitalization in recent studies.13,14
Legionnaires’ disease occurs sporadically and in out-
breaks, with the sporadic form representing 65%–82% of the 
cases.10,11,15 Nevertheless, the number of confirmed commu-
nity outbreaks including more than 100 cases has increased 
in recent years due to the use of Legionella antigenuria.11,15 
Routine testing for Legionella urinary antigen has increased 
the number of diagnostics of Legionnaires’ disease and has 
allowed earlier diagnosis and treatment, greatly improving 
the prognosis.16 This has been particularly true for milder 
cases, mainly in the outbreak setting.17 However, most of the 
knowledge on risk factors, clinical presentation, and outcome 
of community-acquired Legionnaires’ disease is based on 
studies performed before routine urinary antigen testing was 
adopted.18,19 Moreover, recent community outbreaks have 
contributed to the better understanding of Legionnaires’ 
disease in this setting.20–22
Legionella pneumophila has been recognized as an impor-
tant cause of both CAP and nosocomial pneumonia.1,10,11,23 
  Environmental systems, such as air conditioning cooling 
towers, evaporative condensers, whirlpools, and hot spring 
baths have hosted and transmitted the organism. Cases 
of   Legionella pneumonia presumably transmitted from 
  contaminated hot spring spa water have been reported from 
Greece.23 The early recognition of infection due to Legionella 
plays a major role in its treatment and preventing mortality in 
patients with any underlying disease.24,25 In this case, the PCR 
method was lifesaving for the patient because it   confirmed the 
infection, leading to the administration of the right   treatment, 
whereas the first urine antigen test was misleading. This 
way of diagnosing Legionella has been well established in 
  previous published studies, and it should be applied in such 
cases where a differential diagnostic problem exists.26,27
Legionnaires’ disease is an acute bacterial infection 
generally caused by L. pneumophila, primarily involving 
the lower respiratory tract. Outbreaks have been described 
related to a common source of contamination.1 Erythromycin 
has been the treatment of choice ever since a retrospective 
study of the original outbreak in Philadelphia indicated a 
lower mortality rate with this antibiotic. Because   Legionella 
is an intracellular pathogen, antibiotics that penetrate 
  intracellularly are likely to be active against this   pathogen. 
Both fluoroquinolones and macrolides penetrate cells 
well, and both classes demonstrate good in vitro activity. 
  Fluoroquimolones achieve high intracellular levels and have 
a lower minimum inhibitory concentration against Legionella 
Figure 2 Chest X-ray, 2nd day.
Figure 3 Chest X-ray after levofloxacin was added.
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than erythromycin.28 They are more active than erythromycin 
in inhibiting L. pneumophila in different intracellular models. 
Three observational studies with a total of 458 patients have 
indicated that fluoroquinolones (mainly levofloxacin) are 
associated with a superior clinical response when compared 
with that of macrolides (erythromycin and clarithromycin), 
as evidenced by a shorter time to apyrexia, shorter hospital 
stay, and fewer drug-related complications.29–31
However, no randomized trials have been performed 
yet. Mortality appears to be the same. Although it has been 
traditional to add rifampin to erythromycin to treat severe 
legionellosis, an observational cohort study revealed that 
the addition of rifampin to clarithromycin was associated 
with more side effects and a longer hospitalization stay than 
erythromycin alone.30,32 In all cases of severe, life-threatening 
pneumonia, prompt administration of appropriate antibiotics 
is associated with improved outcomes.
This case should urge every clinical doctor to study care-
fully the medical history of a patient and consider alternative 
diagnosis when the patient is not responding to the initial 
treatment. Flouoroquinolones have established an equal if 
not superior therapeutic profile for legionellosis based upon 
published studies.28–30 It should be mentioned at this point 
that a very important limitation of the study was that we were 
unable to take water samples from the spa in order to have a 
solid confirmation of the source of legionellosis.
Conclusion
PCR is a useful tool in the hands of the clinical doctor and 
should be used where possible in suspicious cases, such 
as the above. Also, early antibiotic treatment prevents the 
progression of the infection and should be administered 
upon admission. Finally, flouoroquinolones, and in this 
case   levofloxacin, should be considered an effective and 
  efficacious treatment for legionellosis.
Consent
Written informed consent was obtained from the patient’s 
next-of-kin for publication of this case report and any accom-
panying images.
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